Cargando…
The human immunodeficiency virus protease inhibitor ritonavir is potentially active against urological malignancies
The human immunodeficiency virus protease inhibitor ritonavir has recently been shown to have antineoplastic activity, and its use in urological malignancies is under investigation with an eye toward drug repositioning. Ritonavir is thought to exert its antineoplastic activity by inhibiting multiple...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4399512/ https://www.ncbi.nlm.nih.gov/pubmed/25914545 http://dx.doi.org/10.2147/OTT.S79776 |